Reevaluating Clinical Trial Design

The New York Academy of Sciences by The New York Academy of Sciences

Clinical trials to evaluate new drugs are typically built around one design, the randomized controlled trial, but this method has come under scrutiny in recent years for being expensive, lengthy, and cumbersome. In this...View more